Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives.

cancer metastasis drug design and development hypersialylation sialyltransferase sialyltransferase inhibitors

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
18 Sep 2021
Historique:
received: 30 08 2021
revised: 15 09 2021
accepted: 15 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 12 11 2021
Statut: epublish

Résumé

Potent, cell-permeable, and subtype-selective sialyltransferase inhibitors represent an attractive family of substances that can potentially be used for the clinical treatment of cancer metastasis. These substances operate by specifically inhibiting sialyltransferase-mediated hypersialylation of cell surface glycoproteins or glycolipids, which then blocks the sialic acid recognition pathway and leads to deterioration of cell motility and invasion. A vast amount of evidence for the in vitro and in vivo effects of sialyltransferase inhibition or knockdown on tumor progression and tumor cell metastasis or colonization has been accumulated over the past decades. In this regard, this review comprehensively discusses the results of studies that have led to the recent discovery and development of sialyltransferase inhibitors, their potential biomedical applications in the treatment of cancer metastasis, and their current limitations and future opportunities.

Identifiants

pubmed: 34577144
pii: molecules26185673
doi: 10.3390/molecules26185673
pmc: PMC8470674
pii:
doi:

Substances chimiques

Sialyltransferases EC 2.4.99.-
N-acetyllactosaminide alpha-2,3-sialyltransferase EC 2.4.99.6

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Academia Sinica
ID : AS-KPQ-110-EIMD
Organisme : Academia Sinica
ID : AS-KPQ-109-BioMed
Organisme : Academia Sinica
ID : AS-KPQ-110-BioMed
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST 109-0210-01-18-02
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST 110-0210-01-22-02
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST 109-2113-M-001-014
Organisme : Ministry of Science and Technology, Taiwan
ID : MOST 110-2113-M-001-037

Références

Cancer Metastasis Rev. 2010 Dec;29(4):785-99
pubmed: 20938719
Oncol Rep. 2016 Dec;36(6):3317-3324
pubmed: 27779707
Biochem Biophys Res Commun. 2005 Jun 17;331(4):953-7
pubmed: 15882970
Biochim Biophys Acta. 2002 Sep 19;1572(2-3):263-73
pubmed: 12223274
Oncotarget. 2016 Dec 13;7(50):83570-83587
pubmed: 27835877
Bioorg Med Chem. 2012 Jan 1;20(1):145-56
pubmed: 22154559
PLoS One. 2013 Aug 09;8(8):e73366
pubmed: 23951351
Nat Chem Biol. 2012 Jul;8(7):661-8
pubmed: 22683610
Cancer Res. 2011 Jan 15;71(2):473-83
pubmed: 21224350
Acc Chem Res. 2009 Jun 16;42(6):788-97
pubmed: 19361192
Angew Chem Int Ed Engl. 2001 Jun 1;40(11):2004-2021
pubmed: 11433435
Gastric Cancer. 2016 Jan;19(1):85-97
pubmed: 25532910
Angew Chem Int Ed Engl. 1999 May 17;38(10):1379-1380
pubmed: 29711575
Cancer Res. 2005 Jun 1;65(11):4645-52
pubmed: 15930282
BMC Cancer. 2009 Oct 07;9:357
pubmed: 19811634
Int J Biochem Cell Biol. 2013 Aug;45(8):1748-57
pubmed: 23726834
Biochem Biophys Res Commun. 2017 Jan 22;482(4):758-763
pubmed: 27871859
Sci Rep. 2017 Oct 31;7(1):14428
pubmed: 29089525
Int J Cancer. 2018 Nov 1;143(9):2319-2330
pubmed: 29981167
Protein Cell. 2019 Aug;10(8):550-565
pubmed: 30478534
Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):55-67
pubmed: 23982684
Int J Mol Sci. 2020 Aug 28;21(17):
pubmed: 32872308
J Am Chem Soc. 2007 Sep 5;129(35):10630-1
pubmed: 17696347
J Ovarian Res. 2013 Apr 11;6(1):25
pubmed: 23578204
Glycobiology. 2006 Jan;16(1):54-64
pubmed: 16135558
Org Biomol Chem. 2003 Jul 7;1(13):2229-30
pubmed: 12945690
Oncotarget. 2017 Jan 31;8(5):7691-7709
pubmed: 28032597
Clin Exp Metastasis. 2012 Feb;29(2):155-64
pubmed: 22120474
Nat Rev Drug Discov. 2005 Jun;4(6):477-88
pubmed: 15931257
PLoS One. 2010 Sep 01;5(9):
pubmed: 20824144
Oncol Rep. 2016 Apr;35(4):2131-40
pubmed: 26820593
Glycobiology. 2011 Jun;21(6):716-26
pubmed: 21098518
Curr Drug Targets. 2009 Jun;10(6):483-98
pubmed: 19519350
Leuk Res. 2010 Apr;34(4):463-70
pubmed: 19709745
Nature. 2005 Jul 28;436(7050):518-24
pubmed: 16049480
J Biol Chem. 2008 Aug 8;283(32):22177-85
pubmed: 18676377
Biochem Biophys Res Commun. 2009 May 8;382(3):609-13
pubmed: 19303395
J Org Chem. 2006 May 12;71(10):3696-706
pubmed: 16674039
J Antibiot (Tokyo). 1995 Jun;48(6):447-56
pubmed: 7622428
Glycobiology. 2012 Aug;22(8):1042-54
pubmed: 22534569
Biochemistry. 2007 Jun 19;46(24):7196-204
pubmed: 17518445
Glycobiology. 2005 Aug;15(8):805-17
pubmed: 15843597
Nat Chem Biol. 2011 Mar;7(3):174-81
pubmed: 21258330
Biochim Biophys Acta. 2006 Apr;1760(4):685-92
pubmed: 16439063
Genes (Basel). 2020 Nov 28;11(12):
pubmed: 33260650
Steroids. 2016 Aug;112:54-61
pubmed: 27154753
Chem Commun (Camb). 2006 Feb 14;(6):629-31
pubmed: 16446832
J Med Chem. 2021 Jan 14;64(1):527-542
pubmed: 33371679
Cell Mol Life Sci. 2007 Jul;64(13):1679-700
pubmed: 17497244
Mol Cancer Ther. 2018 Dec;17(12):2689-2701
pubmed: 30237308
J Biol Chem. 2018 Apr 13;293(15):5659-5667
pubmed: 29475939
Nature. 1993 Jun 3;363(6428):418-23
pubmed: 8502295
Glycobiology. 1995 Dec;5(8):741-58
pubmed: 8720072
Bioorg Med Chem Lett. 2003 Oct 6;13(19):3351-4
pubmed: 12951124
Phytochemistry. 2003 Sep;64(1):53-60
pubmed: 12946405
J Antibiot (Tokyo). 1996 Jul;49(7):611-6
pubmed: 8784418
J Org Chem. 2005 Oct 28;70(22):8817-24
pubmed: 16238314
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Chembiochem. 2004 Nov 5;5(11):1517-22
pubmed: 15515100
Glycobiology. 2005 Sep;15(9):887-94
pubmed: 15872150
EBioMedicine. 2016 Jun;8:103-116
pubmed: 27428423
Curr Med Chem. 2008;15(16):1586-605
pubmed: 18673226
J Biol Chem. 2011 Feb 25;286(8):5935-41
pubmed: 21173156
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2893-2897
pubmed: 29711111
Carbohydr Res. 2007 Feb 26;342(3-4):558-66
pubmed: 16989791
J Biol Chem. 1982 Nov 25;257(22):13835-44
pubmed: 7142179
Bioorg Med Chem. 2020 Jul 15;28(14):115561
pubmed: 32616185
Int J Oncol. 2011 Aug;39(2):417-24
pubmed: 21567084
Glycoconj J. 2015 Feb;32(1-2):39-47
pubmed: 25572164
J Med Chem. 2017 Mar 9;60(5):2135-2141
pubmed: 28165727
Angew Chem Int Ed Engl. 2011 Dec 23;50(52):12534-7
pubmed: 22095645
Glycobiology. 2008 Feb;18(2):187-94
pubmed: 18077550
J Biol Chem. 2001 Apr 6;276(14):11007-15
pubmed: 11118434
Curr Opin Chem Biol. 2008 Oct;12(5):565-72
pubmed: 18625334
J Cell Physiol. 2010 May;223(2):492-9
pubmed: 20112294
Biochemistry. 2000 Mar 7;39(9):2261-8
pubmed: 10694392
J Am Chem Soc. 2002 Feb 27;124(8):1632-7
pubmed: 11853437
Biochem Biophys Res Commun. 2006 Mar 10;341(2):614-9
pubmed: 16427612
Glycoconj J. 1998 Apr;15(4):345-54
pubmed: 9613821
Nucleosides Nucleotides Nucleic Acids. 2008 Mar;27(3):244-60
pubmed: 18260009
Biochem Biophys Res Commun. 2001 Jun 8;284(2):466-9
pubmed: 11394903
Med Res Rev. 2017 Mar;37(2):219-270
pubmed: 27678392
FEBS J. 2008 Nov;275(22):5512-26
pubmed: 18959740
Int J Biochem Cell Biol. 2017 Sep;90:48-58
pubmed: 28751193
Haematologica. 2020 Jan 31;105(2):457-467
pubmed: 31101754
J Biol Chem. 2006 Feb 10;281(6):3586-94
pubmed: 16319059
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Oncogene. 2015 Jun 4;34(23):2958-67
pubmed: 25109336
Biochemistry. 1998 Jan 6;37(1):289-97
pubmed: 9425050
Curr Cancer Drug Targets. 2012 Oct;12(8):925-39
pubmed: 22463390
Br J Cancer. 2021 Jan;124(1):76-90
pubmed: 33144696
Mol Nutr Food Res. 2007 Jan;51(1):116-34
pubmed: 17195249
Oncol Rep. 2018 Nov;40(5):2997-3005
pubmed: 30226606
Mol Cancer Ther. 2013 Oct;12(10):1935-46
pubmed: 23974695
Methods Enzymol. 2006;417:247-56
pubmed: 17132509
Oncology. 2003;65(2):139-45
pubmed: 12931020
Medicines (Basel). 2019 Oct 13;6(4):
pubmed: 31614918
Cancer Sci. 2004 May;95(5):377-84
pubmed: 15132763
Biochem Soc Trans. 1996 Aug;24(3):790-5
pubmed: 8878849
J Am Chem Soc. 1997 Jan 29;119(4):681-90
pubmed: 16526129
Mol Med Rep. 2020 Mar;21(3):1449-1460
pubmed: 32016470
Glycobiology. 2021 Jun 3;31(5):530-539
pubmed: 33320246
Mini Rev Med Chem. 2006 Apr;6(4):401-7
pubmed: 16613577
J Med Chem. 2019 Jan 24;62(2):1014-1021
pubmed: 30543426
Glycoconj J. 2004;21(5):205-19
pubmed: 15486453
Biochim Biophys Acta. 2016 Jan;1864(1):143-53
pubmed: 26192491
Eur J Histochem. 2013 Feb 14;57(1):e7
pubmed: 23549466
J Ovarian Res. 2008 Oct 01;1(1):3
pubmed: 19014651
J Biol Chem. 2014 Dec 12;289(50):34627-41
pubmed: 25344606
Ann N Y Acad Sci. 2010 Jan;1183:158-82
pubmed: 20146714
Biochimie. 2001 Aug;83(8):727-37
pubmed: 11530204
Cancer Res. 1995 Oct 1;55(19):4425-31
pubmed: 7545541
Nat Struct Mol Biol. 2009 Nov;16(11):1186-8
pubmed: 19820709
J Physiol Biochem. 2019 Jun;75(2):199-207
pubmed: 30972697
Bioorg Med Chem. 2006 Jan 15;14(2):304-18
pubmed: 16275109
J Antibiot (Tokyo). 1994 Jun;47(6):727-30
pubmed: 8040079
Biol Sci Space. 2003 Jun;17(1):24-44
pubmed: 12897458
Nat Struct Mol Biol. 2004 Feb;11(2):163-70
pubmed: 14730352
Methods Enzymol. 2006;417:256-73
pubmed: 17132510
J Biol Chem. 2021 Jan-Jun;296:100034
pubmed: 33148698
Science. 1977 Feb 11;195(4278):577-80
pubmed: 835014
Cancer Res. 2004 Oct 1;64(19):7050-7
pubmed: 15466199
Mol Med Rep. 2019 Nov;20(5):4499-4506
pubmed: 31702036
Nature. 2009 Jun 18;459(7249):1005-9
pubmed: 19421193
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13789-94
pubmed: 12370411
Blood. 2014 Sep 11;124(11):1765-76
pubmed: 25061176
Cell Death Dis. 2018 Oct 30;9(11):1102
pubmed: 30375371
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11332-7
pubmed: 21709263
Science. 1981 Jun 26;212(4502):1514-6
pubmed: 7233237
Expert Opin Biol Ther. 2014 Apr;14(4):467-82
pubmed: 24479734
Cancers (Basel). 2021 Apr 22;13(9):
pubmed: 33921986
Int J Mol Med. 2011 Jun;27(6):811-9
pubmed: 21424114
Science. 2001 Oct 12;294(5541):380-1
pubmed: 11598302
J Oral Pathol Med. 2020 Mar;49(3):253-259
pubmed: 31747460
Bioorg Med Chem. 2000 Aug;8(8):1937-46
pubmed: 11003139
Oncol Lett. 2019 Aug;18(2):983-989
pubmed: 31423157
Oncotarget. 2015 Oct 27;6(33):34358-74
pubmed: 26452038
Gynecol Oncol. 2005 Feb;96(2):415-22
pubmed: 15661230
J Biol Chem. 2011 Jul 1;286(26):22982-90
pubmed: 21550977
J Biol Chem. 2018 Feb 2;293(5):1610-1622
pubmed: 29233887
Cancer Res. 1986 Jul;46(7):3521-7
pubmed: 3486712
PLoS One. 2013 Jun 14;8(6):e66737
pubmed: 23799130
J Biol Chem. 2009 Jun 5;284(23):15505-16
pubmed: 19336400
J Ovarian Res. 2018 Feb 05;11(1):12
pubmed: 29402301
J Med Chem. 2015 Oct 22;58(20):7972-90
pubmed: 26406919
Glycobiology. 2010 Oct;20(10):1241-50
pubmed: 20534593
Appl Microbiol Biotechnol. 2012 May;94(4):887-905
pubmed: 22526796
Z Naturforsch C J Biosci. 2020 Jan 28;75(1-2):41-49
pubmed: 32031984
J Physiol Biochem. 2018 Aug;74(3):491-501
pubmed: 30006781
Nat Rev Cancer. 2005 Jan;5(1):29-41
pubmed: 15630413
J Mol Recognit. 2018 Feb;31(2):
pubmed: 29119617
Glycobiology. 2018 Nov 1;28(11):898-903
pubmed: 30016515
Cancer Sci. 2017 Feb;108(2):267-276
pubmed: 27906498
Planta Med. 2004 Nov;70(11):1085-7
pubmed: 15549667
Cancer Res. 2013 Apr 1;73(7):2368-78
pubmed: 23358684
Cancer Res. 2008 Jan 15;68(2):388-94
pubmed: 18199532
Int J Mol Sci. 2016 Aug 11;17(8):
pubmed: 27529215
Carbohydr Res. 2013 Aug 30;378:45-55
pubmed: 23374752
Glycoconj J. 2001 Nov-Dec;18(11-12):841-50
pubmed: 12820717
Med Oncol. 2012 Mar;29(1):84-90
pubmed: 21140242
Clin Transl Oncol. 2021 Apr;23(4):902-910
pubmed: 32939659
J Med Chem. 2010 Aug 12;53(15):5607-19
pubmed: 20684602
Gynecol Oncol. 2002 Jul;86(1):45-52
pubmed: 12079299
Chem Commun (Camb). 2012 Oct 9;48(78):9744-6
pubmed: 22914432
Onco Targets Ther. 2020 Jan 29;13:903-914
pubmed: 32099394
Br J Cancer. 1999 Apr;80(1-2):301-8
pubmed: 10390012
Glycoconj J. 2005 Feb;22(1-2):1-11
pubmed: 15864429

Auteurs

Ser John Lynon P Perez (SJLP)

Institute of Chemistry, Academia Sinica, Taipei 115, Taiwan.
Sustainable Chemical Science and Technology, Taiwan International Graduate Program, Academia Sinica, Taipei 115, Taiwan.
Sustainable Chemical Science and Technology, Taiwan International Graduate Program, National Yang Ming Chiao Tung University, Hsinchu 30010, Taiwan.
Department of Applied Chemistry, National Yang Ming Chiao Tung University, Hsinchu 30010, Taiwan.

Chih-Wei Fu (CW)

Institute of Chemistry, Academia Sinica, Taipei 115, Taiwan.
Department of Chemistry, National Central University, Taoyuan City 32001, Taiwan.

Wen-Shan Li (WS)

Institute of Chemistry, Academia Sinica, Taipei 115, Taiwan.
Doctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
Ph.D. Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan.
Department of Medicinal and Applied Chemistry, College of Life Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Department of Chemistry, College of Science, Tamkang University, New Taipei City 251, Taiwan.
Biomedical Translation Research Center (BioTReC), Academia Sinica, Taipei 115, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH